Dr. Daubert is a Professor of Medicine with tenure at Duke University School of Medicine, member of the Duke Clinical Research Institute faculty and Associate Director of the Heart Center at Duke University Medical Center. He is ABIM Board Certified in Internal Medicine and Clinical Cardiac Electrophysiology.

Dr. Daubert founded and developed the electrophysiology program at the University of Rochester. He returned to Duke as Chief of the Section of Cardiac Electrophysiology serving until 2019. His research interests include sudden cardiac death, ICD/CRT indications and programming, inherited arrhythmias, sports cardiology and atrial fibrillation. He has served on the MADIT Executive Committees and numerous other steering, events and data monitoring committees. He chaired the Heart Rhythm Society Clinical Cardiology Electrophysiology Program Director Subcommittee and is Vice Chair of the Education Committee.

He was awarded the Simon Dack Award for Outstanding Scholarship from The Journal of the American College of Cardiology (JACC) in 2010, and Elite Reviewer status multiple years. He is the Associate Editor of JACC Clinical Electrophysiology, Senior Consulting Editor at JACC Heart Failure and Associate Editor for The Journal of Interventional Cardiac Electrophysiology. He is on the editorial boards at JACC, Heart Rhythm, The Journal of Interventional Cardiac Electrophysiology, Pacing and Clinical Electrophysiology, The American Journal of Cardiology, The Journal of Electrocardiology and The American Heart Journal. 

Dr. Daubert graduated from Williams College and received a medical degree at Thomas Jefferson University. He received his postgraduate medical training at Duke, serving as chief resident for one year.

As of February 2026, Dr. Daubert reported the following external relationships:

Funding for clinical trial expenses, salary support and staff, paid to Duke University, from the following companies:  

• Cardurion, serving as a principal investigator.  
• Rocket Pharmaceuticals, serving as a principal investigator.  

Service on data and safety monitoring boards and end-point review committees for the following companies, with honoraria:  

• Arga Medtech, for service on a clinical events committee.  
• Biosense Webster, for service chair on an end-point review committee.  
• Medical Center of the University of Rochester, for service as a data and safety monitoring board member.  
• National Institutes of Health, for service as a data and safety monitoring board member.  

Service on a research-related expert panel or advisory board for the following companies, with honoraria:    

• Boston Scientific, for service on a steering committee, receiving honoraria.  
• Medical Center of the University of Rochester, for serving on a steering committee, without compensation.  
• Medtronic, for serving on an advisory board for quality and recalls, receiving honoraria.  

Dr. Daubert also reports receiving royalties for authorship, paid through Duke University.  

Dr. Bhave is a Professor of Medicine at Wake Forest School of Medicine and a cardiologist practicing at Atrium Health Wake Forest Baptist Cardiology – Davie. He also serves as Program Director of the Electrophysiology Fellowship and Associate Program Director for the Cardiology Fellowship at Wake Forest. His clinical interests include novel device therapies and catheter ablation of atrial and ventricular arrhythmias. His research centers around atrial fibrillation and stroke prevention. He is ABIM Board Certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology. 

Dr. Bhave completed medical school at the University of Colorado and internal medicine residency training and a cardiology fellowship at the University of California, San Francisco. He completed a clinical cardiac electrophysiology fellowship at the McGaw Medical Center of Northwestern University. 

As of February 2026, Dr. Bhave reported no ongoing external relationships.   

Dr. Lloyd is a Professor of Medicine and the lab director for Emory University Hospital Cardiac Electrophysiology Center. He is the immediate past director of the Electrophysiology Fellowship Program at Emory University and serves as the Vice Chair of the Heart Rhythm Society's Digital Education Committee. He is ABIM Board Certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.

As of April 2026, Dr. Lloyd reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Emory University, from the following companies:  

• Boston Scientific  
• Medtronic   

Research-related consulting for the following companies, with compensation for travel expenses and honoraria:    

• Abbott Vascular  
• Boston Scientific  
• Medtronic  

Dr. Nazer is a cardiac electrophysiologist and Associate Professor of Medicine and Bioengineering at the University of Washington. He is ABIM Board Certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.

As of February 2026, Dr. Nazer reported the following external relationships:

Service on a research-related advisory board for the following companies, with compensation for travel expenses and honoraria:    

• Biosense Webster Inc. 
• Siemens  

Dr. Russo, ABIM Board Certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology, is Professor of Medicine at Cooper Medical School of Rowan University, Academic Chief of the Division of Cardiology, Director of Electrophysiology and Arrhythmia Services, and Director of the Clinical Cardiac Electrophysiology Fellowship Program at Cooper University Hospital in Camden, New Jersey. Dr. Russo previously served on the ABIM Cardiovascular Test-Writing Committee and the American Board of Medical Specialties Continuing Board Certification Vision for the Future Commission. She is the Chair of the ABIM Cardiovascular Board and Chair-Elect of the ABIM Council. 

She is past president of the Heart Rhythm Society (HRS), current member of the American Heart Association (AHA) Atrial Fibrillation Systems of Care Advisory Committee and member of the American College of Cardiology (ACC) Cardio-Obstetrics Council. She previously served on or chaired multiple ACC, AHA and HRS committees, subcommittees and working groups. In addition, she has served as co-chair or member on several guideline and consensus documents, as well as Appropriate Use criteria writing groups. She also serves on editorial boards for several peer-reviewed journals and is a current Associate Editor for Circulation: Arrhythmia and Electrophysiology. She has served on steering committees, events committees and data safety monitoring committees for several clinical trials. Her areas of research interest include implantable cardioverter defibrillators, atrial fibrillation therapies, sex differences in arrhythmias and the role of digital health in arrhythmia management. 

Dr. Russo earned a Bachelor of Science in Microbiology at the University of Rochester and a medical degree at the SUNY Downstate Health Sciences University. She completed an internal medicine residency at Drexel University College of Medicine (then the Medical College of Pennsylvania) in Philadelphia and fellowships in cardiovascular disease and electrophysiology at the University of Medicine and Dentistry of New Jersey.  

As of February 2026, Dr. Russo reported the following ongoing external relationships:

Funding for clinical trial expenses and staff, paid to Cooper University, from the following companies:  

• Abbott Laboratories 
• Novartis AG 
• Orchestra BioMed  

Service on data and safety monitoring boards for the following companies, with honoraria:  

• Biosense Webster Inc. 

Service on a research-related steering committee or advisory board for the following companies, without compensation:  

• Medtronic  
• PaceMate  

Work as an author or editor for the following companies, with compensation as listed:  

• UpToDate, receiving compensation as an editor and author for chapters related to implantable cardioverter defibrillator therapy. 

Dr. Voigt is a cardiac electrophysiologist and ABIM Board Certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology. He is the director of the electrophysiology laboratory at UPMC Shadyside and an Associate Professor of Medicine at the University of Pittsburgh School of Medicine.

Dr. Voigt joined the UPMC Heart and Vascular Institute in 2007. His clinical interests include treatment of heart rhythm disorders using noninvasive and invasive means. He utilizes techniques such as catheter ablation to treat atrial and ventricular arrhythmias, implantation of pacemaker-defibrillators and left atrial appendage occlusion. Dr. Voigt enjoys teaching and participates in clinical research evaluating new techniques for treatment of atrial fibrillation and novel devices to treat heart failure and slow heart rhythms. He is a fellow in the Heart Rhythm Society and the American College of Cardiology. He has served in multiple roles with ABIM, including participating in the standard-setting process for the clinical electrophysiology certification examinations on the Collaborative Maintenance Pathway and on the Cardiovascular Disease Item-Writing Task Force.

He completed his undergraduate studies at Dartmouth College where he majored in history, graduating cum laude. He received his medical degree from the University of Pittsburgh School of Medicine and completed his internal medicine residency at Georgetown University Hospital in Washington, D.C. He completed his cardiology and electrophysiology fellowship training at the University of Pittsburgh Medical Center.

As of March 2026, Dr. Voigt reported no ongoing external relationships.